Novartis AG (NYSE:NVS)

85.33
Delayed Data
As of 4:02pm ET
 +0.13 / +0.15%
Today’s Change
72.67
Today|||52-Week Range
94.19
+1.63%
Year-to-Date
Medicines Company (MDCO) Reports Q4 Loss, Revenues Slump Y/Y
Feb 22 / Zacks.com - Paid Partner Content
Intercept (ICPT) Q4 Earnings & Sales Lag on Dull Ocaliva
Feb 15 / Zacks.com - Paid Partner Content
Ligand (LGND) Q4 Earnings & Revenues Top, 2018 View Solid
Feb 22 / Zacks.com - Paid Partner Content
Roche's Rituxan Gets Priority Review for Label Expansion
Feb 14 / Zacks.com - Paid Partner Content
Teva's Problems Continue to Mount With No Relief in Sight
Feb 21 / Zacks.com - Paid Partner Content
Lilly's Taltz Positive in Phase III Label Expansion Study
Feb 14 / Zacks.com - Paid Partner Content
Novartis Psoriasis Drug Cosentyx Positive in SCALP Study
Feb 20 / Zacks.com - Paid Partner Content
Teva Stock Falls as Novartis Brings Another Copaxone Generic
Feb 14 / Zacks.com - Paid Partner Content
What's in Store for Ligand (LGND) This Earnings Season?
Feb 19 / Zacks.com - Paid Partner Content
Generic Drugmakers to Dump as Teva's Woes Continue in 2018
Feb 13 / Zacks.com - Paid Partner Content
AstraZeneca's (AZN) Imfinzi Gets FDA Nod for Label Expansion
Feb 19 / Zacks.com - Paid Partner Content
Intercept Starts OCA Trial for NASH Patients With Cirrhosis
Feb 13 / Zacks.com - Paid Partner Content
Celgene Reports Positive Data on Dermatology Drug Otezla
Feb 19 / Zacks.com - Paid Partner Content
Can Jakafi Performance Drive Incyte's (INCY) Q4 Earnings?
Feb 12 / Zacks.com - Paid Partner Content
Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles
Feb 16 / TheStreet.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Novartis, BP and Biogen
Feb 09 / Zacks.com - Paid Partner Content
Roche (RHHBY) to Acquire Flatiron Health for $1.9 Billion
Feb 16 / Zacks.com - Paid Partner Content
Trump wants to fix 'injustice' of high drug prices. But can he?
Jan 31 / CNNMoney.com
Incyte (INCY) Beats on Q4 Revenues on Strong Jakafi Sales
Feb 15 / Zacks.com - Paid Partner Content